Abivax stockABVX
Abivax trades at $84.17, 43.4% below its 52-week high (Dec 24, 2025). The price is below its 50- and 200-day averages, a downtrend. −37.6% year to date, −15.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Dec 14, 2026.
Ratings, candles, signals and the screener for ABVX — after you log in
Open the terminalFrequently asked questions about Abivax
What is the Abivax stock price?
At the close on Nov 5, 2026: $84.17 (−5.94% on the day). 52-week high: $148.83 on Dec 24, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Abivax report earnings?
The next quarterly report is on Dec 14, 2026. Last quarter, earnings per share changed −44% year over year, revenue +16%.
Does Abivax pay dividends?
No, Abivax does not pay dividends.
Where does Abivax trade and how to buy it?
Ticker ABVX, exchange Nasdaq, listed since 2023. You can buy it through a broker with access to US exchanges.
Should I buy Abivax now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ABVX are in the terminal after you log in.